Table 2.
Variables | Insulinoma group (n = 44) | Hypoglycemia group (n = 26) | Control group (n = 31) | F value | P value |
---|---|---|---|---|---|
HBG (mmol/L) | 9.00 ± 3.10 | 9.65 ± 4.47 | 8.27 ± 1.51 | 0.95 | 0.628 |
LBG (mmol/L)* | 2.76 ± 0.92 | 3.93 ± 0.75 | 4.67 ± 0.63 | 9.74 | 0.001 |
MBG (mmol/L) | 5.10 ± 1.20 | 5.99 ± 1.63 | 5.83 ± 0.66 | 2.86 | 0.085 |
SD | 1.46 ± 0.79 | 1.25 ± 1.15 | 0.92 ± 0.28 | 1.03 | 0.526 |
HbA1c (%) | 4.97 ± 0.50 | 5.27 ± 0.39 | 5.52 ± 0.21 | 2.14 | 0.101 |
FBG (mmol/L)* | 3.37 ± 1.29 | 4.83 ± 0.40 | 4.74 ± 0.37 | 14.72 | 0.000 |
FINS (mU/L)* | 22.63 ± 15.09 | 8.04 ± 6.19 | 8.60 ± 3.60 | 10.72 | 0.000 |
FCP (ng/mL)* | 3.17 ± 1.18 | 2.17 ± 1.04 | 2.23 ± 0.69 | 5.07 | 0.011 |
IRI* | 0.45 ± 0.36 | 0.09 ± 0.07 | 0.10 ± 0.05 | 12.80 | 0.000 |
HBG high blood glucose, LBG low blood glucose, MBG mean blood glucose, SD standard deviation, HbA1c glalycosylated hemoglobin A1c, FBG fasting blood glucose, FINS fasting insulin, FCP fasting C-peptide, IRI Insulin Release Index
*P < 0.05